Description
Biomatik's de novo antibody sequencing platform works specifically with IgG antibodies and does not require access to the cell line, and guarantee 100% coverage of the desired regions as well as accuracy. With 200µg of antibody (≥90%), we can identify all amino acids (distinguish between isoleucine and leucine) and deliver the sequencing data within as little as 2-3 weeks. With the antibody sequencing data, we can then produce your recombinant antibody with guaranteed antibody affinity by ELISA.